Press release
Duchenne Muscular Dystrophy (DMD) Therapeutics Market Focusing on Top Key Players - Eli Lilly and Company, Pfizer, Inc., and BioMarin Pharmaceutical, Inc
Duchenne Muscular Dystrophy (DMD) is the serious type of muscle diseases that affects the male population at the age of four and make them lose their ability to walk by 12. Due to its rare effects, it is termed as orphan diseases and can be found for approximately 1 in 3,500 male population. Compared to the previous decade, several new treatment methods have been developed recently to detect and treat the diseases, which is collectively known as Duchenne muscular dystrophy (DMD) therapeutics.
Request free sample @ https://www.researchcosmos.com/request/global-duchenne-muscular-dystrophy-therapeutics-market-outlo/4958600
Factors Driving the Growth of Global Duchenne Muscular Dystrophy Therapeutics Market:
The average life expectancy of the children affected by this muscular dystrophy is 26 years, however, it can be extended to 30 years or 40 years with regular medical care. The general symptoms of this disease include weakness in muscles of the hips, pelvic area, thighs, shoulders, arms, legs, and trunk. Although there is no cure for this diseases, new therapeutics have been developed to control its progression in the body. Molecular-based therapies like mutation suppression or exon skipping are the most common treatments for the Duchenne Muscular Dystrophy (DMD).
There are some significant factors driving the global Duchenne Muscular Dystrophy (DMD) therapeutics market such as the increasing development of new drugs, rise in the research and development, growing demand for the therapeutics among the patients, mounting cases of other chronic diseases cardiovascular, neurovascular, and arthritis, increasing availability health insurance, growth in the health care spending of the people, and so on. However, the delayed process for the prognosis is the major restraining aspect of the market expansion.
Browse details of 80 pages research report developed on Global Duchenne Muscular Dystrophy Market @ https://www.researchcosmos.com/reports/global-duchenne-muscular-dystrophy-therapeutics-market-outlo/4958600
Geographic Segmentation:
Based on the geography, North America accounts for the largest share of the global Duchenne Muscular Dystrophy therapeutics market due to the launch of innovative products, healthcare expenditure, investments in the research and development, and government supportive initiatives. Europe is next in line to North America, and the Asia Pacific region is expected to register higher growth rate in the future.
Some of the Leading Companies in the Global Duchenne Muscular Dystrophy Therapeutics Market:
Some of the leading contributors to the global Duchenne Muscular Dystrophy therapeutics market are Eli Lilly and Company, Pfizer, Inc., Santhera Pharmaceuticals Holding, Nobelpharma Co., Ltd., Sarepta Therapeutics, Inc., Tivorsan Pharmaceuticals, Acceleron Pharma, Inc., Asklepios Kliniken GmbH, FibroGen, Inc., and BioMarin Pharmaceutical, Inc.
About Us:
Research Cosmos is a provider of standard and customized market research, business intelligence and consulting services across more than 100 domains in different industries of the world. We host the trending market reports of the world’s top-notch publishing companies, offering services to a wide range of customers from students to fortune 500 companies and discloses the hidden opportunities in every leading industry of the world.
Contact:
Kevin Stewart
Global Sales Manager
Research Cosmos
www.researchcosmos.com
Blog: https://acutemarketinsights.com
Blog: https://marketreportsweb.com/
kevin@researchcosmos.com
+1 888 709 8757
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Duchenne Muscular Dystrophy (DMD) Therapeutics Market Focusing on Top Key Players - Eli Lilly and Company, Pfizer, Inc., and BioMarin Pharmaceutical, Inc here
News-ID: 1221234 • Views: …
More Releases from Research Cosmos
Mobile Phone Insurance Market Size to Reach USD 32.24 Bn By 2025
The size of the Global mobile phone insurance market is estimated to reach USD 32.24 billion by 2025, growing at a CAGR of 12.5%, as per the recently published report by Research Cosmos. It is worth to claim insurance for mobile phones as we are spending a lot of money on purchasing. The policies include accidental damage, water damage, and screen cracking.
Browse details of the report @ https://www.researchcosmos.com/reports/mobile-phone-insurance-market/199557834
Growing utilization…
Social Employee Recognition Systems Market Predicted to grow at a CAGR of xx By …
Social Employee Recognition Systems Market Analysis Size, Growth rate and Overview:
Social Employee Recognition Systems Market was valued at USD xx million in 2018 and is expected to reach almost USD xx million by the end of 2025, growing at a CAGR of around xx% over the predicted period.
Throughout the world, social employee recognition systems have expanded dramatically to address the need to move away from traditional methods and programs of…
More Releases for Duchenne
Duchenne Muscular Dystrophy (DMD) Drugs Market Report
As per the research conducted by GME, the Duchenne Muscular Dystrophy (DMD) Drugs Market will grow with a CAGR value of 41.3 percent by 2026. The global market for Duchenne muscular dystrophy is foreseen to grow due to accelerated research and development activities, expanded patient awareness for effective treatments, and the launch of new medications Moreover, the disease's increasing prominence is likely to drive the global duchenne muscular dystrophy market…
Global Duchenne Muscular Dystrophy Market Research Report 2015-2025
About the Global Duchenne Muscular Dystrophy Market Research Report 2015-2025:
Global Global Duchenne Muscular Dystrophy Market Research Report 2015-2025 2020 Research Report is divided into various key segments like device type, material, applications, and end users. The report is thoroughly analyzed and studied by the researchers to offer deep insights on each of these segments with statistics. This information is beneficial for the manufacturers in the industry to plan their policies…
Global Duchenne Muscular Dystrophy Therapeutics Market Productions, Statistics 2 …
Qyresearchreports include new market research report "Global Duchenne Muscular Dystrophy Therapeutics Market Size, Status and Forecast 2022" to its huge collection of research reports.
The general market for Duchenne Muscular Dystrophy Therapeutics has been analysed on various points of view that are practically present in the scenario, and have affected the market situation to the large extent. The report also presents exceptional experience and data identified with global Duchenne Muscular Dystrophy…
Duchenne Muscular Dystrophy - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Duchenne Muscular Dystrophy - Pipeline Review, H2 2017 to its growing collection of premium market research reports.
Summary
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Duchenne Muscular Dystrophy - Pipeline Review, H2 2017, provides an overview of the Duchenne Muscular Dystrophy (Genetic Disorders) pipeline landscape.
Duchenne muscular dystrophy is a condition which causes muscle weakness. DMD is an X-linked disorder.…
Duchenne Muscular Dystrophy (DMD) Treatment Market - Global Industry Insights, T …
Duchenne muscular dystrophy (DMD) is a genetic disorder characterized by progressive muscle degeneration and weakness. DMD is caused due to alteration in gene sequence coding for dystrophin proterin, which is present the muscle. It is a rare muscle disease which majorly affects males. The symptoms includes intellectual disability, muscle weakness and, difficulty in walking and breathing. Congestive heart failure, mental impairment, pneumonia or respiratory failure are some of the…
Duchenne Muscular Dystrophy (DMD) Market Forecast Research Reports Offers Key In …
Duchenne muscular dystrophy (DMD) is a genetic disorder characterized by muscle degeneration and weakness. Duchenne muscular dystrophy (DMD) cause due to lack of protein known as “dystrophin” which causes muscles deterioration and break down, leads to difficulty in walking and general mobility. DMD is a one of the most progressive childhood neuromuscular disorders. It affects mostly boys, but occasionally girls are affected. According to Muscular Dystrophy Australia, in 2016, Duchenne…
